Enlivex Therapeutics
ENLV
ENLV
11 hedge funds and large institutions have $3.36M invested in Enlivex Therapeutics in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+7
Holders Change %
+175%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
1
Reduced
1
Closed
2
Calls
$300K
Puts
$801K
Net Calls
-$501K
Net Calls Change
-$501K
Top Buyers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$264K |
2 |
UBS Group
Zurich,
Switzerland
|
+$103K |
3 |
Citadel Advisors
Miami,
Florida
|
+$91K |
4 |
Bank of America
Charlotte,
North Carolina
|
+$26K |
5 |
Morgan Stanley
New York
|
+$24K |
Top Sellers
1 |
Renaissance Technologies
New York
|
-$164K |
2 |
Jane Street
New York
|
-$64K |
3 |
SPIA
Steward Partners Investment Advisory
New York
|
-$8K |